Cavium Networks, Inc. (NASDAQ: CAVM), Hyatt Hotels (NYSE: H), Coach (NYSE: COH), MicroStrategy Incorporated (NASDAQ: MSTR), Trimble Navigation (NASDAQ: TRMB) and Parker-Hannifin Co. (NYSE: PH) price targets adjusted by analysts.
Cavium Networks, Inc. (CAVM) had its price target lowered by Stifel Nicolaus from $50.00 to $44.00. They have a “Buy” rating on the company.
Hyatt Hotels (H) had its price target raised by FBR Capital from $48.00 to $51.00. They have an “Outperform” rating on the company.
Coach (COH) had its price target raised by JPMorgan Chase & Co. (NYSE:JPM) to $68.00. They have an “Overweight” rating on the company.
MicroStrategy Incorporated (MSTR) had its price target lowered by FBR Capital from $140.00 to $134.00. They have a “Market Perform” rating on the company.
Trimble Navigation (TRMB) had its price target lowered by Needham & Company from $54.00 to $45.00. They have a “Buy” rating on the company.
Parker-Hannifin Co. (PH) had its price target lowered by UBS AG (NYSE:UBS) from $94.00 to $77.00. They have a “Neutral” rating on the company.
Thursday, August 4, 2011
Cavium (CAVM) (H) (COH) (MSTR) (TRMB) (PH) Price Targets Changed
Thursday, April 28, 2011
Qlik (QLIK) (MSL) (MSTR) (PERY) Get Coverage Initiations from Analysts
Qlik Technologies Inc (NASDAQ: QLIK), MidSouth Bancorp, Inc. (NYSE: MSL), MicroStrategy Incorporated (NASDAQ: MSTR), Perry Ellis International, Inc. (NASDAQ: PERY) now getting coverage initiated by these analysts.
Raymond James (NYSE:RJF) initiated coverage on MidSouth Bancorp, Inc. (MSL). They started them with a “Market Perform” rating.
BMO Capital Markets initiated coverage on MicroStrategy Incorporated (MSTR). They started with an “Outperform” rating and a price target of $180.
Deutsche Bank (NYSE:DB) initiated coverage on Perry Ellis International, Inc. (PERY). They started with a “Buy” rating and a price target of $33.
BMO Capital Markets initiated coverage on Qlik Technologies Inc (QLIK). They started with a “Market Perform” rating and a price target of $29.
Wednesday, April 27, 2011
Perry Ellis (PERY) (REGN) (MSTR) (QLIK) Get Ratings Initiations
Regeneron Pharmceuticals (NASDAQ:REGN), MicroStrategy (NASDAQ:MSTR), Qlik Tech (QLIK) and Perry Ellis (NASDAQ:PERY) all had rating initiated on them from several brokerages.
Regeneron Pharmceuticals (REGN) has coverage resumed on them from Boenning & Scattergood, which started them off with an "Outperform" rating. They placed a price target of $58 on REGN.
MicroStrategy (MSTR) had coverage initiated on them by BMO Capital Markets, which started them off with an "Outperform.' They have a price target of $180 on MicroStrategy.
Qlik Tech (QLIK) also had coverage initiated on them by BMO Capital Markets, receiving a "Market Perform" rating from them. They placed a price target of $29 on Qlik.
Deutshe Bank (NYSE:DB) initiated coverage on Perry Ellis (PERY), starting them off with a "Buy" rating.
Thursday, March 31, 2011
MicroStrategy (MSTR) New Data Hound for Groupon
MicroStrategy (NASDAQ:MSTR) has been hired by Groupon to go through the numerous daily deals of the company concerning services and products acquired in order to get an accurate picture of what its customers are searching for.
Included in the data will be demographics, discounts offered, location and daily deals customers participate in.
The data gleaned is expected to give Groupon more insight into the behavior and habits of its customers for the purpose of providing more targeted offerings.
MicroStrategy closed Wednesday at $133.69, gaining $10.69, or 8.69 percent.
Thursday, January 27, 2011
MicroStrategy's (NASDAQ:MSTR) Growing Head Count Pressuring Profits ... For Now
MicroStrategy (NASDAQ:MSTR) will have profits under pressure for awhile, even with the revenue growth they've experienced. Once they plateau, margins should start to expand.
FBR says, "Last night, MicroStrategy reported a better-than-expected quarter with meaningful revenue upside and EPS. Revenue upside was driven by both license and support/services revenues, which supports our checks that the MicroStrategy 9 product cycle still has legs even after over a year of availability. In our view, the healthy license upside is driven by a combination of: (1) improving demand, (2) a meaningful 4Q budget flush, and (3) growing head count, which has increased the company’s distribution capacity. Despite the meaningful revenue upside, the company’s previous head-count ramp continues to pressure profitability. The significant ramp in support/services head count led to lower-than-expected support/services gross margins. As the sales force continues to ramp up, we expect operating margin expansion should follow."
FBR Capital reiterates a "Market Perform" rating on MicroStrategy (MSTR), which closed Wednesday at $105.02, gaining $12.01, or 12.91 percent. FBR raised their price target on MicroStrategy from $85 to $100.